Ironically, in the long run, hiding the influence of Big Pharma on smoking cessation policy does not advance the cessation field, but brings it to a grinding halt. The public, and tobacco control practitioners themselves, need to understand the deeply ingrained roots of Big Pharma within the tobacco control movement, especially in the smoking cessation field. Failure to do so will lead to blind following of an industry-based agenda. This is precisely what has happened in tobacco control.

In a grant proposal that was subsequently funded by the state of California's Tobacco-Related Disease Research Program (TRDRP), Dr. Manuela Martin-Greens and colleagues from the University of California, Riverside exhibited their fortune-telling skills, claiming to know the results of their proposed lab experiments on mice before actually performing the studies.

To add icing to the cake, Medical News Today that: "researchers from this latest study say thirdhand smoke is left on surfaces and ages over time, becoming increasingly more toxic. The team suggests second and thirdhand smoke are just as harmful as firsthand smoke."

LAST：wax clearomizer of super good quality glass globe clearomizer wax atomizer |NEXT：2014 rebuildable ego ce5 with light weight blister pack hot selling eGo ce5